After successfully completing the last 2-editions of UECC, Unite Scientific Explores is glad to announce the 3rd edition of the "Unite Explores Cancer Conference (UECC-2026)" which is going to be held during September 07-08, 2026 in Brussels, Belgium. We have heartily opened the invitation to Participants who are involved and working in Cancer Research.
UECC-2026 consists of multiple presentations, interesting breakout sessions, interactive discussions, and demonstrations. Our strong objective is to provide the best platform for the community of researchers, physician assistants, pharmacists, doctors, professors, students, and other health care professionals related to Cancer Research to share their research experiences and to improve their networking opportunities. Here we Unite the world-class researchers, International Communities, and Industrial heads in this event and promote quality research to international scientific associations, and cancer societies that identify future demands and clinical needs in the field of Cancer & Breast Cancer. Our Congress includes current application studies of surgery, Immunotherapy radiation therapy, chemotherapy, Hormone therapy, Supportive Care and Targeted drugs in Cancer.
UECC-2026 consists of multiple presentations, interesting breakout sessions, interactive discussions, and demonstrations. Our strong objective is to provide the best platform for the community of researchers, physician assistants, pharmacists, doctors, professors, students, and other health care professionals related to Cancer Research to share their research experiences and to improve their networking opportunities. Here we Unite the world-class researchers, International Communities, and Industrial heads in this event and promote quality research to international scientific associations, and cancer societies that identify future demands and clinical needs in the field of Cancer & Breast Cancer. Our Congress includes current application studies of surgery, Immunotherapy radiation therapy, chemotherapy, Hormone therapy, Supportive Care and Targeted drugs in Cancer.
